ACAD - ACADIA Pharmaceuticals Inc

Healthcare - Sector
Coverage

ACAD is currently covered by 22 analysts with average potential upside of $8.54 (33.2%) backed by 177 price targets and 282 ratings. Analyst's average stock valuation to be materialised ratio is 60.02% with an average time for price targets to be met of 194.91 days.

Most recent stock forecast was given by YATIN SUNEJA from GUGGENHEIM on 03-Jan-2023.

Highest price target for ACAD is 50, Lowest price target is 13, average price target is 31.5.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

22

$2.09 (10.50%)

1 months 3 days ago

1/5 (20%)

$6.24 (23.43%)

42

Hold

15

$-4.91 (-24.66%)

17

1 months 16 days ago

4/8 (50%)

$4.52 (15.89%)

81

Hold

12

$-7.91 (-39.73%)

15

3 months 2 days ago

6/8 (75%)

$1.08 (4.42%)

73

Buy

21

$1.09 (5.47%)

21

3 months 3 days ago

1/13 (7.69%)

$10.98 (46.43%)

119

Hold

17

$-2.91 (-14.62%)

29

3 months 5 days ago

1/2 (50%)

$1.42 (6.71%)

64

Show more analysts